questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines tumorales
Protéines oncogènes
Protéines oncogènes : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines oncogènes : Questions médicales les plus fréquentes",
"headline": "Protéines oncogènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines oncogènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2026-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines oncogènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines tumorales",
"url": "https://questionsmedicales.fr/mesh/D009363",
"about": {
"@type": "MedicalCondition",
"name": "Protéines tumorales",
"code": {
"@type": "MedicalCode",
"code": "D009363",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéines de fusion oncogènes",
"alternateName": "Oncogene Proteins, Fusion",
"url": "https://questionsmedicales.fr/mesh/D015514",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de fusion oncogènes",
"code": {
"@type": "MedicalCode",
"code": "D015514",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine oncogène tpr-met",
"alternateName": "Oncogene Protein tpr-met",
"url": "https://questionsmedicales.fr/mesh/D050490",
"about": {
"@type": "MedicalCondition",
"name": "Protéine oncogène tpr-met",
"code": {
"@type": "MedicalCode",
"code": "D050490",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.500.660"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéines E7 de papillomavirus",
"alternateName": "Papillomavirus E7 Proteins",
"url": "https://questionsmedicales.fr/mesh/D050725",
"about": {
"@type": "MedicalCondition",
"name": "Protéines E7 de papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D050725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.520.420"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine oncogène v-akt",
"alternateName": "Oncogene Protein v-akt",
"url": "https://questionsmedicales.fr/mesh/D051058",
"about": {
"@type": "MedicalCondition",
"name": "Protéine oncogène v-akt",
"code": {
"@type": "MedicalCode",
"code": "D051058",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.520.750.788"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine oncogène v-cbl",
"alternateName": "Oncogene Protein v-cbl",
"url": "https://questionsmedicales.fr/mesh/D050722",
"about": {
"@type": "MedicalCondition",
"name": "Protéine oncogène v-cbl",
"code": {
"@type": "MedicalCode",
"code": "D050722",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.520.750.817"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine oncogène v-crk",
"alternateName": "Oncogene Protein v-crk",
"url": "https://questionsmedicales.fr/mesh/D050736",
"about": {
"@type": "MedicalCondition",
"name": "Protéine oncogène v-crk",
"code": {
"@type": "MedicalCode",
"code": "D050736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.520.750.846"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes",
"alternateName": "Proto-Oncogene Proteins",
"url": "https://questionsmedicales.fr/mesh/D011518",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes",
"code": {
"@type": "MedicalCode",
"code": "D011518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Axl Receptor Tyrosine Kinase",
"alternateName": "Axl Receptor Tyrosine Kinase",
"url": "https://questionsmedicales.fr/mesh/D000094963",
"about": {
"@type": "MedicalCondition",
"name": "Axl Receptor Tyrosine Kinase",
"code": {
"@type": "MedicalCode",
"code": "D000094963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.013"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-11 analogue à Bcl-2",
"alternateName": "Bcl-2-Like Protein 11",
"url": "https://questionsmedicales.fr/mesh/D000072224",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-11 analogue à Bcl-2",
"code": {
"@type": "MedicalCode",
"code": "D000072224",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.025"
}
}
},
{
"@type": "MedicalWebPage",
"name": "c-Mer Tyrosine kinase",
"alternateName": "c-Mer Tyrosine Kinase",
"url": "https://questionsmedicales.fr/mesh/D000076202",
"about": {
"@type": "MedicalCondition",
"name": "c-Mer Tyrosine kinase",
"code": {
"@type": "MedicalCode",
"code": "D000076202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.037"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cycline D1",
"alternateName": "Cyclin D1",
"url": "https://questionsmedicales.fr/mesh/D019938",
"about": {
"@type": "MedicalCondition",
"name": "Cycline D1",
"code": {
"@type": "MedicalCode",
"code": "D019938",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tyrosine kinase-3 de type fms",
"alternateName": "fms-Like Tyrosine Kinase 3",
"url": "https://questionsmedicales.fr/mesh/D051941",
"about": {
"@type": "MedicalCondition",
"name": "Tyrosine kinase-3 de type fms",
"code": {
"@type": "MedicalCode",
"code": "D051941",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.114"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kinase Janus-2",
"alternateName": "Janus Kinase 2",
"url": "https://questionsmedicales.fr/mesh/D053614",
"about": {
"@type": "MedicalCondition",
"name": "Kinase Janus-2",
"code": {
"@type": "MedicalCode",
"code": "D053614",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.117"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lipocaline-2",
"alternateName": "Lipocalin-2",
"url": "https://questionsmedicales.fr/mesh/D000071068",
"about": {
"@type": "MedicalCondition",
"name": "Lipocaline-2",
"code": {
"@type": "MedicalCode",
"code": "D000071068",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.123"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine tyrosine kinase p56(lck) spécifique des lymphocytes",
"alternateName": "Lymphocyte Specific Protein Tyrosine Kinase p56(lck)",
"url": "https://questionsmedicales.fr/mesh/D019860",
"about": {
"@type": "MedicalCondition",
"name": "Protéine tyrosine kinase p56(lck) spécifique des lymphocytes",
"code": {
"@type": "MedicalCode",
"code": "D019860",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.128"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-2 homologue de MutS",
"alternateName": "MutS Homolog 2 Protein",
"url": "https://questionsmedicales.fr/mesh/D051718",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-2 homologue de MutS",
"code": {
"@type": "MedicalCode",
"code": "D051718",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.130"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Proto-oncogène Mas",
"alternateName": "Proto-Oncogene Mas",
"url": "https://questionsmedicales.fr/mesh/D000090063",
"about": {
"@type": "MedicalCondition",
"name": "Proto-oncogène Mas",
"code": {
"@type": "MedicalCode",
"code": "D000090063",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.166"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-abl",
"alternateName": "Proto-Oncogene Proteins c-abl",
"url": "https://questionsmedicales.fr/mesh/D016315",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-abl",
"code": {
"@type": "MedicalCode",
"code": "D016315",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.167"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-akt",
"alternateName": "Proto-Oncogene Proteins c-akt",
"url": "https://questionsmedicales.fr/mesh/D051057",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-akt",
"code": {
"@type": "MedicalCode",
"code": "D051057",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.168"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-bcl-2",
"alternateName": "Proto-Oncogene Proteins c-bcl-2",
"url": "https://questionsmedicales.fr/mesh/D019253",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-bcl-2",
"code": {
"@type": "MedicalCode",
"code": "D019253",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.169"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine Mcl-1",
"alternateName": "Myeloid Cell Leukemia Sequence 1 Protein",
"url": "https://questionsmedicales.fr/mesh/D064549",
"about": {
"@type": "MedicalCondition",
"name": "Protéine Mcl-1",
"code": {
"@type": "MedicalCode",
"code": "D064549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.169.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéine Mcl-1",
"alternateName": "Myeloid Cell Leukemia Sequence 1 Protein",
"url": "https://questionsmedicales.fr/mesh/D064549",
"about": {
"@type": "MedicalCondition",
"name": "Protéine Mcl-1",
"code": {
"@type": "MedicalCode",
"code": "D064549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.169.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-bcr",
"alternateName": "Proto-Oncogene Proteins c-bcr",
"url": "https://questionsmedicales.fr/mesh/D051562",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-bcr",
"code": {
"@type": "MedicalCode",
"code": "D051562",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.171"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéines de fusion bcr-abl",
"alternateName": "Fusion Proteins, bcr-abl",
"url": "https://questionsmedicales.fr/mesh/D016044",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de fusion bcr-abl",
"code": {
"@type": "MedicalCode",
"code": "D016044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.171.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéines de fusion bcr-abl",
"alternateName": "Fusion Proteins, bcr-abl",
"url": "https://questionsmedicales.fr/mesh/D016044",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de fusion bcr-abl",
"code": {
"@type": "MedicalCode",
"code": "D016044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.171.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-cbl",
"alternateName": "Proto-Oncogene Proteins c-cbl",
"url": "https://questionsmedicales.fr/mesh/D050721",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-cbl",
"code": {
"@type": "MedicalCode",
"code": "D050721",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.172"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-crk",
"alternateName": "Proto-Oncogene Proteins c-crk",
"url": "https://questionsmedicales.fr/mesh/D050737",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-crk",
"code": {
"@type": "MedicalCode",
"code": "D050737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-fes",
"alternateName": "Proto-Oncogene Proteins c-fes",
"url": "https://questionsmedicales.fr/mesh/D051578",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-fes",
"code": {
"@type": "MedicalCode",
"code": "D051578",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.177"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-fyn",
"alternateName": "Proto-Oncogene Proteins c-fyn",
"url": "https://questionsmedicales.fr/mesh/D051076",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-fyn",
"code": {
"@type": "MedicalCode",
"code": "D051076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.180"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-hck",
"alternateName": "Proto-Oncogene Proteins c-hck",
"url": "https://questionsmedicales.fr/mesh/D051572",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-hck",
"code": {
"@type": "MedicalCode",
"code": "D051572",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.181"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-kit",
"alternateName": "Proto-Oncogene Proteins c-kit",
"url": "https://questionsmedicales.fr/mesh/D019009",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-kit",
"code": {
"@type": "MedicalCode",
"code": "D019009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.183"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-met",
"alternateName": "Proto-Oncogene Proteins c-met",
"url": "https://questionsmedicales.fr/mesh/D019859",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-met",
"code": {
"@type": "MedicalCode",
"code": "D019859",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.186"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-mos",
"alternateName": "Proto-Oncogene Proteins c-mos",
"url": "https://questionsmedicales.fr/mesh/D017231",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-mos",
"code": {
"@type": "MedicalCode",
"code": "D017231",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.187"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-pim-1",
"alternateName": "Proto-Oncogene Proteins c-pim-1",
"url": "https://questionsmedicales.fr/mesh/D051573",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-pim-1",
"code": {
"@type": "MedicalCode",
"code": "D051573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.191"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-ret",
"alternateName": "Proto-Oncogene Proteins c-ret",
"url": "https://questionsmedicales.fr/mesh/D051096",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-ret",
"code": {
"@type": "MedicalCode",
"code": "D051096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.194"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-vav",
"alternateName": "Proto-Oncogene Proteins c-vav",
"url": "https://questionsmedicales.fr/mesh/D051567",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-vav",
"code": {
"@type": "MedicalCode",
"code": "D051567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.198"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-yes",
"alternateName": "Proto-Oncogene Proteins c-yes",
"url": "https://questionsmedicales.fr/mesh/D051575",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-yes",
"code": {
"@type": "MedicalCode",
"code": "D051575",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.199"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes p21(ras)",
"alternateName": "Proto-Oncogene Proteins p21(ras)",
"url": "https://questionsmedicales.fr/mesh/D016283",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes p21(ras)",
"code": {
"@type": "MedicalCode",
"code": "D016283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes pp60(c-src)",
"alternateName": "Proto-Oncogene Proteins pp60(c-src)",
"url": "https://questionsmedicales.fr/mesh/D016392",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes pp60(c-src)",
"code": {
"@type": "MedicalCode",
"code": "D016392",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.202"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kinases raf",
"alternateName": "raf Kinases",
"url": "https://questionsmedicales.fr/mesh/D048490",
"about": {
"@type": "MedicalCondition",
"name": "Kinases raf",
"code": {
"@type": "MedicalCode",
"code": "D048490",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.204"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes B-raf",
"alternateName": "Proto-Oncogene Proteins B-raf",
"url": "https://questionsmedicales.fr/mesh/D048493",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes B-raf",
"code": {
"@type": "MedicalCode",
"code": "D048493",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.204.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-raf",
"alternateName": "Proto-Oncogene Proteins c-raf",
"url": "https://questionsmedicales.fr/mesh/D019908",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-raf",
"code": {
"@type": "MedicalCode",
"code": "D019908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.204.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes B-raf",
"alternateName": "Proto-Oncogene Proteins B-raf",
"url": "https://questionsmedicales.fr/mesh/D048493",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes B-raf",
"code": {
"@type": "MedicalCode",
"code": "D048493",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.204.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-raf",
"alternateName": "Proto-Oncogene Proteins c-raf",
"url": "https://questionsmedicales.fr/mesh/D019908",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-raf",
"code": {
"@type": "MedicalCode",
"code": "D019908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.204.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur de type 3 des facteurs de croissance fibroblastique",
"alternateName": "Receptor, Fibroblast Growth Factor, Type 3",
"url": "https://questionsmedicales.fr/mesh/D051498",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur de type 3 des facteurs de croissance fibroblastique",
"code": {
"@type": "MedicalCode",
"code": "D051498",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.792"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur du facteur de stimulation des colonies de macrophages",
"alternateName": "Receptor, Macrophage Colony-Stimulating Factor",
"url": "https://questionsmedicales.fr/mesh/D016186",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur du facteur de stimulation des colonies de macrophages",
"code": {
"@type": "MedicalCode",
"code": "D016186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700.800"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines oncogènes",
"alternateName": "Oncogene Proteins",
"code": {
"@type": "MedicalCode",
"code": "D015513",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xiaofeng Jin",
"url": "https://questionsmedicales.fr/author/Xiaofeng%20Jin",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University Ningbo 315211, China."
}
},
{
"@type": "Person",
"name": "Jian Wang",
"url": "https://questionsmedicales.fr/author/Jian%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University Ningbo 315211, China."
}
},
{
"@type": "Person",
"name": "Qian Li",
"url": "https://questionsmedicales.fr/author/Qian%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University Ningbo 315211, China."
}
},
{
"@type": "Person",
"name": "Hui Zhuang",
"url": "https://questionsmedicales.fr/author/Hui%20Zhuang",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University Ningbo 315211, China."
}
},
{
"@type": "Person",
"name": "Jianye Yang",
"url": "https://questionsmedicales.fr/author/Jianye%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University Ningbo 315211, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Oncogenic",
"datePublished": "2024-08-14",
"url": "https://questionsmedicales.fr/article/39156764",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mco2.685"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of phosphorylation efficiency on the oncogenic properties of the protein E7 from high-risk HPV.",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39127239",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.virusres.2024.199446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38813086",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcell.2024.1403396"
}
},
{
"@type": "ScholarlyArticle",
"name": "The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription.",
"datePublished": "2023-11-18",
"url": "https://questionsmedicales.fr/article/37980390",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s42003-023-05540-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37324001",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2023.1170482"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines tumorales",
"item": "https://questionsmedicales.fr/mesh/D009363"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines oncogènes",
"item": "https://questionsmedicales.fr/mesh/D015513"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines oncogènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines oncogènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines oncogènes",
"description": "Comment détecte-t-on les protéines oncogènes ?\nQuels tests sont utilisés pour le diagnostic ?\nLes biopsies sont-elles nécessaires ?\nQuels marqueurs tumoraux sont associés ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D015513?page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines oncogènes",
"description": "Quels symptômes sont liés aux protéines oncogènes ?\nLes symptômes sont-ils spécifiques ?\nComment les symptômes évoluent-ils ?\nY a-t-il des signes précurseurs ?\nLes symptômes peuvent-ils être confondus ?",
"url": "https://questionsmedicales.fr/mesh/D015513?page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines oncogènes",
"description": "Peut-on prévenir les cancers liés aux oncogènes ?\nLes dépistages sont-ils recommandés ?\nL'alimentation joue-t-elle un rôle ?\nLe tabagisme influence-t-il le risque ?\nL'exercice physique est-il bénéfique ?",
"url": "https://questionsmedicales.fr/mesh/D015513?page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines oncogènes",
"description": "Quels traitements ciblent les protéines oncogènes ?\nLa chimiothérapie est-elle efficace ?\nQuelles sont les nouvelles approches thérapeutiques ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D015513?page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines oncogènes",
"description": "Quelles complications peuvent survenir ?\nLes métastases sont-elles une complication ?\nComment gérer les complications ?\nLes complications affectent-elles le pronostic ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D015513?page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines oncogènes",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes infections peuvent-elles augmenter le risque ?\nLe stress influence-t-il le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D015513?page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les protéines oncogènes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les protéines oncogènes peuvent être détectées par des tests génétiques et des analyses protéomiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la PCR, l'immunohistochimie et le séquençage de l'ADN."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent être nécessaires pour analyser la présence de protéines oncogènes."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme HER2 et KRAS sont souvent associés à des protéines oncogènes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à localiser les tumeurs, mais ne détecte pas directement les protéines oncogènes."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux protéines oncogènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le type de cancer, incluant fatigue, douleur et perte de poids."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes ne sont pas spécifiques et peuvent être communs à plusieurs maladies."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec la progression de la maladie et la croissance tumorale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes précurseurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des changements dans les habitudes intestinales peuvent être précurseurs."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec d'autres conditions non cancéreuses."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les cancers liés aux oncogènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives, comme un mode de vie sain, peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "Les dépistages sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent aider à détecter précocement certains cancers."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de certains cancers associés aux oncogènes."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque majeur pour plusieurs cancers liés aux oncogènes."
}
},
{
"@type": "Question",
"name": "L'exercice physique est-il bénéfique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut diminuer le risque de cancer et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les protéines oncogènes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies ciblées, comme les inhibiteurs de tyrosine kinase, ciblent ces protéines."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie peut être utilisée, mais elle n'est pas spécifique aux protéines oncogènes."
}
},
{
"@type": "Question",
"name": "Quelles sont les nouvelles approches thérapeutiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques et immunothérapies sont des approches prometteuses en cours d'étude."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être personnalisés en fonction des mutations spécifiques des oncogènes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires comme des nausées et de la fatigue."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation du cancer et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Les métastases sont-elles une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les métastases sont une complication fréquente des cancers liés aux oncogènes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de complications peut aggraver le pronostic et réduire les chances de survie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent persister longtemps après le traitement du cancer."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le tabagisme et l'exposition à des agents carcinogènes."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de développer un cancer augmente avec l'âge en raison de mutations accumulées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles augmenter le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le HPV, sont liées à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affaiblir le système immunitaire, augmentant potentiellement le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques et à la pollution peut augmenter le risque de cancer."
}
}
]
}
]
}
Chimeric RNAs, distinct from DNA gene fusions, have emerged as promising therapeutic targets with diverse functions in cancer treatment. However, the functional significance and therapeutic potential ...
The Human papillomavirus (HPV) causes tumors in part by hijacking the host cell cycle and forcing uncontrolled cellular division. While there are more than 200 genotypes of HPV, 15 are classified as h...
PHD (plant homeodomain) finger proteins emerge as central epigenetic readers and modulators in cancer biology, orchestrating a broad spectrum of cellular processes pivotal to oncogenesis and tumor sup...
TAZ::CAMTA1 is a fusion protein found in over 90% of Epithelioid Hemangioendothelioma (EHE), a rare vascular sarcoma with an unpredictable disease course. To date, how TAZ::CAMTA1 initiates tumour for...
The Four Jointed Box 1 (FJX1) gene has been implicated in the upregulation of various cancers, highlighting its crucial role in oncology and immunity. In order to better understand the biological func...
We analyzed the expression profiles and prognostic value of FJX1 using data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx). Copy number alterations (CNAs), mutations, and DN...
Our study indicated that FJX1 expression was high in most cancers and was significantly associated with poor prognosis. High FJX1 expression was also linked to significant alterations in CNA, DNA meth...
Our research findings demonstrate that FJX1 is a new prognostic factor with a significant role in tumor immunity. Our results highlight the importance of further exploring the potential of targeting F...
The unobtrusive cold environmental temperature can be linked to the development of cancer. This study, for the first time, envisaged cold stress-mediated induction of a zinc finger protein 726 (ZNF726...
Human papillomavirus (HPV) infection poses a significant health challenge, particularly in low- and middle-income countries (LMIC), where limited healthcare access and awareness hinder vaccine accessi...
Y box binding protein 3 (YBX3) is an indispensable factor for protein synthesis, cellular growth, and proliferation, and is intricately involved in the progression of diverse tumor types. The objectiv...
Recent studies have uncovered various physiological functions of CDK5 in many nonneuronal tissues. Upregulation of CDK5 and/or its activator p35 in neurons promotes healthy neuronal functions, but the...
In the absence of targeted treatment options, neoadjuvant chemotherapy (NACT) is applied widely for triple-negative breast cancer (TNBC). Response to NACT is an important parameter predictive of oncol...